GS Investments’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351 | Hold |
200
| – | – | ﹤0.01% | 112 |
|
|
2025
Q1 | $272 | Hold |
200
| – | – | ﹤0.01% | 117 |
|
|
2024
Q4 | $759 | Hold |
200
| – | – | ﹤0.01% | 124 |
|
|
2024
Q3 | $540 | Hold |
200
| – | – | ﹤0.01% | 127 |
|
|
2024
Q2 | $620 | Hold |
200
| – | – | ﹤0.01% | 123 |
|
|
2024
Q1 | $908 | Hold |
200
| – | – | ﹤0.01% | 129 |
|
|
2023
Q4 | $1.38K | Hold |
200
| – | – | ﹤0.01% | 124 |
|
|
2023
Q3 | $1.26K | Hold |
200
| – | – | ﹤0.01% | 128 |
|
|
2023
Q2 | $1.66K | Hold |
200
| – | – | ﹤0.01% | 130 |
|
|
2023
Q1 | $880 | Buy |
+200
| New | +$880 | ﹤0.01% | 144 |
|